Connection

Chadrick Denlinger to ras Proteins

Back to Details
This is a "connection" page, showing publications Chadrick Denlinger has written about ras Proteins.
Chadrick Denlinger
Connection Strength
0.044
ras Proteins
  1. Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer. Cancer Chemother Pharmacol. 2015 Jan; 75(1):17-23.
    View in: PubMed
    Score: 0.028
  2. Novel targeted therapies for non-small cell lung cancer. Thorac Surg Clin. 2006 Nov; 16(4):353-66.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.